Analyst Upgrades – Calithera Biosciences (NASDAQ:CALA) Stock Gets Upgraded By Citigroup from Neutral to Buy

Analyst Ratings For Calithera Biosciences (NASDAQ:CALA)

Story continues below

Today, Calithera Biosciences (NASDAQ:CALA) stock received an upgrade by Citigroup from Neutral to Buy.

Some recent analyst ratings include

  • 2/16/2018-Citigroup Upgrade from a “Neutral ” rating to a ” Buy” rating.
  • 10/5/2017-William Blair initiated coverage with a Outperform rating.
  • 6/12/2017-HC Wainwright Reiterated Rating of Buy.
  • 6/6/2017-Wells Fargo & Co Reiterated Rating of Outperform.
  • 4/3/2017-Leerink Swann Reiterated Rating of Outperform .
  • 3/28/2017-JMP Securities Reiterated Rating of Outperform.

Recent Insider Trading Activity For Calithera Biosciences (NASDAQ:CALA)
Calithera Biosciences (NASDAQ:CALA) has insider ownership of 16.30% and institutional ownership of 72.89%.

  • On 9/28/2017 Adage Capital Partners Gp, L.L, Major Shareholder, sold 576,000 with an average share price of $15.64 per share and the total transaction amounting to $9,008,640.00.
  • On 7/17/2017 Keith Orford, VP, sold 2,120 with an average share price of $18.31 per share and the total transaction amounting to $38,817.20.
  • On 7/6/2017 Curtis Hecht, SVP, sold 700 with an average share price of $18.00 per share and the total transaction amounting to $12,600.00.
  • On 5/19/2017 Curtis Hecht, SVP, sold 650 with an average share price of $16.00 per share and the total transaction amounting to $10,400.00.
  • On 3/22/2017 Adage Capital Partners Gp, L.L, Major Shareholder, bought 487,804 with an average share price of $10.25 per share and the total transaction amounting to $4,999,991.00.
  • On 3/13/2017 Curtis Hecht, SVP, sold 600 with an average share price of $14.00 per share and the total transaction amounting to $8,400.00.
  • On 11/16/2016 Adage Capital Partners Gp, L.L, Major Shareholder, bought 500,000 with an average share price of $3.15 per share and the total transaction amounting to $1,575,000.00.

Recent Trading Activity for Calithera Biosciences (NASDAQ:CALA)
Shares of Calithera Biosciences closed the previous trading session at 7.73 up +0.78 11.15% with 999586 shares trading hands.

An ad to help with our costs